Top Stock Movers Sept 23, 2026: BENF, WHLR, VSA

BENF — Beneficient (+433.2%)

Beneficient closed at $2.87, up a staggering +433.2% on volume of 171.4 million shares — more than 8× its 20-day average of 21.2 million. For a company with a market cap of just $193.7 million, that kind of turnover signals extreme speculative interest and a very thin, volatile market.

Why it moved: Multiple same-day outlets — including Benzinga, QuiverQuant, and The Cryptonomist — covered the move, with The Cryptonomist specifically framing it as a debt-relief rally. The stock had been in a prolonged downtrend (it sits 72.5% below its 52-week high), and a debt-relief catalyst in that context can spark an outsized snap-back as short sellers rush to cover. A note of caution: a headline from timothysykes.com referenced traders also watching an AltLens Tech Pivot angle, though the debt-relief narrative appears to be the primary driver cited by financial press.

The technical picture reflects the chaos: StockSetups flagged a hammer candle (a single-session reversal signal where price probes lower then closes near the top of the range), an RSI of 65 (approaching overbought territory), and a gap of +442.4% from the prior close. The squeeze score of 69/100 is elevated — short interest stands at 115,886 shares with 14.0 days to cover (meaning, at average volume, it would take short sellers two weeks to buy back their borrowed shares, adding fuel to a squeeze). Free float is a razor-thin 9.3%, which means even modest buying pressure can move the stock violently in either direction.

Smart-money signals are worth noting: StockSetups shows a smart-money score of 84/100, with three insider buys totaling $35K on September 15 — CEO James Silk, Derek Fletcher, and Peter Cangany all purchased shares. There is also one active 13D/G stake of 7.5%. That insider buying predated today's move. However, a September 16 SEC 8-K flagged as dilution-bearish is a real headwind; dilutive filings can cap or reverse short-covering rallies quickly. BENF appeared in this morning's premarket movers recap and has appeared in prior recaps going back to September 15 — this is a name with a history of explosive, short-lived moves.

WHLR — Wheeler Real Estate Investment Trust (+190.4%)

Wheeler REIT closed at $5.43, up +190.4%, on volume of 10.0 million shares vs. a 20-day average of 6.3 million — roughly 1.6× normal, which is modest relative to the size of the move. The company's market cap is only $10.5 million, making it a micro-cap name where thin liquidity can translate a small order flow into a massive percentage swing.

Why it moved: The clearest piece of corporate action on file is a September 17 8-K describing bylaw changes that alter security holder rights (flagged by TipRanks on September 21). Bylaw amendments affecting shareholder rights can sometimes precede or accompany restructuring events, debt conversions, or balance-sheet actions that traders interpret as value-unlocking. The stock also appeared alongside ARTL in a Pluang headline noting its 191% move. Beyond that, the specific catalyst is not detailed in the available research; the move has characteristics of a technical gap-and-go on very low float liquidity.

Wheeler's technical profile is extreme: RSI of 77 (overbought), ADX of 41 (a strong trend reading), and a gap of +178.6% from the prior close. It sits 99.9% below its 52-week high — yes, that is essentially a near-zero stock that has been grinding lower for a long time. The squeeze score is 65/100 with short volume at 61% of today's total. Days to cover is just 0.1, so there is no structural short squeeze fuel here — this move was driven by buying, not forced short covering. Free float is 70.3%, so supply is not constrained the way it is with BENF.

Insider activity shows HRT Financial LP made several small purchases in early July, and Stilwell Activist Investments (which holds a 50% disclosed stake) has been accumulating. Reddit's r/all-stocks ranked WHLR at #42 with 12 mentions today, suggesting some retail momentum community attention. WHLR's conviction score of 33/100 and a D grade from StockSetups reflect a technically weak trend backdrop despite today's explosive session.

VSA — VisionSys AI Inc (+89.9%)

VisionSys AI closed at $3.76, up +89.9%, on volume of 6.8 million shares — a stunning 17.4× its 20-day average of 392,009 shares. That volume-to-average ratio is the highest among today's movers and signals a genuine, broad-based surge in trading interest for a stock that almost nobody was watching yesterday.

Why it moved: There are no headlines or SEC filings on file for today's move. With no identified catalyst, this appears to be a momentum- and technically-driven move — the kind of explosive, low-float name that can get swept up in a broader speculative session. Traders should treat the absence of a known catalyst as a risk flag, not a green light.

The technical read shows an RSI of 63 and ADX of 35 (indicating a developing trend), but the MA stack is mixed and the stock sits 99.8% below its 52-week high — a pattern common to heavily diluted or restructured micro-caps. The gap on the day was minimal at just +1.0%, meaning the big move happened during the regular session rather than pre-open. StockSetups shows a squeeze score of 51/100 and short volume of 59%, with days to cover at just 0.6 — not enough structural short interest to explain a near-doubling. The conviction score of 38/100 and D grade reflect the speculative, low-quality chart context. With no catalyst and 17× normal volume, VSA is a prime candidate for a sharp reversal when that volume dries up.

ARTL — Artelo Biosciences (+75.2%)

Artelo Biosciences closed at $7.27, up +75.2%, on 10.1 million shares — roughly 16.4× its 20-day average of 613,253. The $33.4 million market cap healthcare name saw a genuine, news-driven surge today.

Why it moved: The catalyst is clearly identified. Artelo filed a new provisional patent application covering its drug candidate ART27.13 for obesity — both as a standalone therapy and in combination with GLP-1 receptor agonists (the class that includes drugs like Ozempic and Wegovy) — following what the company described as unexpected nonclinical findings (reported by Yahoo Finance). In the current market environment, any credible connection to the GLP-1/obesity drug space draws intense investor attention. TipRanks noted the stock was up over 200% at intraday peaks before it settled to a 75% close-to-close gain.

The technical setup reflects a stock that has been deeply depressed: ARTL sits 93.1% below its 52-week high, and the MA stack is bearish. StockSetups flagged an inverted hammer candle — a pattern that can signal a potential reversal but requires confirmation in subsequent sessions. RSI is 59 (not yet overbought) and ADX is 47 (a very strong trend reading, consistent with a sharp directional move). The squeeze score is 36/100, short volume is 56%, and days to cover is just 0.2 — so this was a patent-driven rally, not a short squeeze. Free float is 81.5%, meaning there is plenty of supply available if sellers emerge. The conviction score of 28/100 and D grade underscore that the technical base remains weak outside of today's catalyst.

BFRG — BullFrog AI Holdings (+55.0%)

BullFrog AI closed at $0.93, up +55.0%, on volume of 110.0 million shares — more than 12× its 20-day average of 9.0 million. At a market cap of $17.2 million, that is enormous dollar-volume activity relative to the company's size.

Why it moved: The most concrete catalyst on file is insider buying by two senior executives on the same day as the surge. According to Investing.com, CFO Joshua Blacher purchased $26,425 in BFRG stock and CEO Vininder Singh purchased $44,917 — both on September 23. When a company's top two executives buy stock in the open market on the same day the stock is already surging, it tends to amplify retail confidence. Benzinga also covered the surge. No specific corporate news announcement (partnership, trial result, etc.) is present in the available data, but the executive purchases are a tangible, verifiable signal.

StockSetups gives BFRG its strongest technical profile of today's five movers: a conviction score of 73/100, a grade of B, and a trend-template score of 4 (the highest possible, indicating the stock is aligned across multiple timeframe moving averages in a bullish configuration). The RSI is 82 (overbought — a caution flag after a 55% single-day run), and the ADX is 27. The gap was +30.4% pre-open, meaning the stock started the day already elevated and continued higher. BFRG's technical rank of 97/100 means it outperforms nearly the entire StockSetups universe on a composite technical basis today. Free float is 85.3% and the squeeze score is just 32/100, confirming this was a buying-driven move, not a short squeeze. Reddit's r/all-stocks had it at rank #112 with 4 mentions — modest social buzz. The B grade and high conviction score make BFRG the most technically credible name on today's list, though a 55% single-session move at $0.93 still carries substantial risk of a pullback.

The bottom line

Today's five biggest gainers — BENF, WHLR, VSA, ARTL, and BFRG — collectively illustrate how diverse the catalysts behind explosive single-day moves can be: a debt-relief narrative, a bylaw change, a mystery momentum surge, a patent filing tied to the hottest drug category in the market, and same-day insider purchases. What they share is extreme volatility, small market caps, and the very real possibility of giving back a large portion of today's gains in the sessions ahead.

Chasing stocks after 55%–433% single-day moves is high-risk. Extended gainers frequently pull back sharply once the catalyst-driven volume exhausts itself — especially names with weak long-term technical bases (BENF, WHLR, VSA, and ARTL all sit 72%–99.9% below their 52-week highs). Short squeezes and momentum surges can reverse without warning. Dilutive SEC filings (see BENF's September 16 8-K) can cap recoveries. Always size positions to what you can afford to lose, use defined stops, and do your own research before acting.

StockSetups scans the full ~12,300-stock US universe after every close, detecting confirmed chart patterns, computing conviction and short-squeeze scores, and sorting setups into actionable lanes — so you can find the next mover before it moves. Check back tomorrow for the September 24 premarket recap, and see what else the scan surfaced from today's session. You can also review this morning's premarket recap and yesterday's close recap for context on how these names have been developing.